Katherine Sisson

Katherine Sisson

Auto-generated profile, based on publicly available information

Katherine Sisson

Department of Pathology, Norfolk and Norwich University Hospitals NHS Foundation Trust , Norwich

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Oral Oncology
Verified
Journal Article
Closed access
CACaroline Rachael Anderson
Caroline Rachael Anderson
KSKatherine Sisson
Katherine Sisson
MMMarc D. Moncrieff
Marc D. Moncrieff

26 June 2026 in Rheumatology
Verified
Journal Article
Closed access
CMChetan B Mukhtyar
Chetan B Mukhtyar
KAKaren Ashurst
Karen Ashurst
FCFiona L Coath
Fiona L Coath
GDGeorgina Ducker
Georgina Ducker
SFSarah Fordham
Sarah Fordham
RWRichard A Watts
Richard A Watts
Objectives: The ANCA associated vasculitides (AAV) are rare diseases with poor outcomes if untreated. Over a 30-year period we have investigated the changing incidence of AAV and its subtypes—granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic GPA (EGPA), proteinase 3 AAV (PR3 AAV), and myeloperoxidase AAV (MPO AAV). Methods: The study population included adults in the county of Norfolk, UK between 1991 and 2020. Diagnosis of AAV was made clinically and supported by EMA classification. Classification by ANCA subtype was possible from 2001. The overall incidence of clinical phenotypes GPA, MPA and EGPA, and serological phenotypes PR3 AAV and MPO AAV were analysed for temporal fluctuations and seasonality. Results: From 1991 to 2020, the incidence (95% CI) of AAV, GPA, MPA and EGPA was 25.1 (22.5, 27.9), 13.6 (11.7, 15.8), 8.5 (7.0, 10.2) and 3.0 (2.1, 4.0) per million person-years, respectively. From 2001 to 2020, the incidence (95% CI) of PR3 AAV and MPO AAV was 11.5 (9.4, 13.9) and 11.7 (9.6, 14.1) per million person-years, respectively. The temporal fluctuations in the incidence of EGPA and PR3 AAV were not significant. The incidence of GPA has a statistical periodicity of 9 years. The incidence of MPO AAV demonstrated a linear rise from 2001 to 2020 (R2 = 0.66). Our patients are getting older at diagnosis. Seasonality was not observed. Conclusion: This is the longest incidence study of AAV in the world. The incidence of GPA showed a 9-year periodicity. The incidence of MPO AAV rose steadily. Its relationship to older age at diagnosis needs formal exploration.